The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Stroke prevention in atrial fibrillation: Past, present and future: Comparing the guidelines and practical decision-making
Abstract
Summary: Concepts and our approaches to stroke prevention in atrial fibrillation (AF) have changed markedly over the last decade. There has been an evolution over the approach to stroke and bleeding risk assessment, as well as new treatment options. An increasing awareness of AF has led to calls to improve the detection of and population screening for AF. Stroke and bleeding risk assessment continues to evolve, and the ongoing debate on balance between simplicity and practicality, against precision medicine will continue. In this review article, we provide an overview of past, present and the (likely) future concepts and approaches to stroke prevention in AF. We propose three simple steps (the Birmingham ‘3-step’) that offers a practical management pathway to help streamline and simplify decision-making for stroke prevention in patients with AF. Note: The review process for this paper was fully handled by Christian Weber, Editor in Chief.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ruff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793 · cited 2×
“The historical randomised controlled trials (RCTs) comparing warfarin to placebo or control, conducted two decades ago, clearly showed that warfarin reduced stroke/systemic embolism by 64 % and all-cause mortality by 26 % (5, 6).”
BackgroundIdarucizumab for Dabigatran Reversal
Pollack, C. V., Reilly, P. A., Eikelboom, J., Glund, S., Verhamme, P., Bernstein, R. A., Dubiel, R., Huisman, M. V., Hylek, E. M., Kamphuisen, P. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1502000 · Cited by 1,552
Hendriks, J. M. L., de Wit, R., Crijns, H. J. G. M., Vrijhoef, H. J. M., Prins, M. H., Pisters, R., Pison, L. A. F. G., Blaauw, Y., & Tieleman, R. G. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs071 · Cited by 409
Hughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-08-0508 · Cited by 371
Self-citationWagstaff, A. J., Overvad, T. F., Lip, G. Y. H., & Lane, D. A. (2014) · QJM · doi:10.1093/qjmed/hcu054 · Cited by 176
Self-citationAdjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00018 · Cited by 173
Skjøth, F., Nielsen, P., Larsen, T. B., & Lip, G. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-07-0565 · Cited by 106 · cited 2×
“Notwithstanding the fact that even one stroke risk factor confers an excess risk of stroke and death, and that OAC has a positive NCB with one or more stroke risk factors (25), the CHA2DS2-VASc score should be used in a stepwise approach to initially identify ‘low risk’ patients (Step 1), defined as a CHA2DS2-VASc sco…”
Self-citationAgnelli, G., & Paciaroni, M. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-08-0667 · Cited by 52
Cited by
Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge
Lippi, G., Sanchis-Gomar, F., & Cervellin, G. (2021) · International Journal of Stroke · doi:10.1177/1747493019897870 · Cited by 1,437
Antithrombotic Therapy for Atrial Fibrillation
Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R., Freedman, B., Lane, D. A., Ruff, C. T., Turakhia, M., Werring, D., et al. (2018) · Chest · doi:10.1016/j.chest.2018.07.040 · Cited by 939
Self-citationMobile Photoplethysmographic Technology to Detect Atrial Fibrillation
Guo, Y., Wang, H., Zhang, H., Liu, T., Liang, Z., Xia, Y., Yan, L., Xing, Y., Shi, H., Li, S., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.08.019 · Cited by 489
Self-citationLip, G. Y. H., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Gupta, K., Luo, X., Mardekian, J., Friend, K., Nadkarni, A., et al. (2018) · Stroke · doi:10.1161/strokeaha.118.020232 · Cited by 323
Self-citationNielsen, J. C., Lin, Y.-J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., Dagres, N., Di Toro, D., Eckhardt, L. L., Ellenbogen, K., et al. (2020) · EP Europace · doi:10.1093/europace/euaa065 · Cited by 98
Self-citation
Metadata
- Authors
- Lip, G. Y. H., Freedman, B., De Caterina, R., & Potpara, T. S.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2017
- Volume
- 117
- Issue
- 07
- Pages
- 1230-1239
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2623061081
- Cited by
- 400
- References
- 9
- FWCI
- 48.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stroke prevention in atrial fibrillation: Past, present and future: Comparing the guidelines and practical decision-making. https://app.cochat.ai/papers/10.1160/th16-11-0876
- The paper
- Lip, G. Y. H., Freedman, B., De Caterina, R., & Potpara, T. S. (2017). Stroke prevention in atrial fibrillation: Past, present and future: Comparing the guidelines and practical decision-making. Thrombosis and Haemostasis. https://doi.org/10.1160/th16-11-0876
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
